Wagner Siegfried Karl, Bountziouka Vasiliki, Hysi Pirro, Rahi Jugnoo Sangeeta
Institute of Ophthalmology, University College London, London, UK.
NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology London, UK.
EClinicalMedicine. 2024 Mar 7;70:102493. doi: 10.1016/j.eclinm.2024.102493. eCollection 2024 Apr.
Amblyopia is a common neurodevelopmental condition and leading cause of childhood visual impairment. Given the known association between neurodevelopmental impairment and cardiometabolic dysfunction in later life, we investigated whether children with amblyopia have increased risk of cardiometabolic disorders in adult life.
This was a cross-sectional and longitudinal analysis of 126,399 United Kingdom Biobank cohort participants who underwent ocular examination. A subset of 67,321 of these received retinal imaging. Data analysis was conducted between November 1st 2021 and October 15th 2022. Our primary objective was to investigate the association between amblyopia and a number of components of metabolic syndrome and individual cardiometabolic diseases. Childhood amblyopia, dichotomised as or by adulthood, cardiometabolic disease and mortality were defined using ophthalmic assessment, self-reported, hospital admissions and death records. Morphological features of the optic nerve and retinal vasculature and sublayers were extracted from retinal photography and optical coherence tomography. Associations between amblyopia and cardiometabolic disorders as well as retinal markers were investigated in multivariable-adjusted regression models.
Individuals with persisting amblyopia (n = 2647) were more likely to be obese (adjusted odds ratio (95% confidence interval): 1.16 (1.05; 1.28)), hypertensive (1.25 (1.13; 1.38)) and diabetic (1.29 (1.04; 1.59)) than individuals without amblyopia (controls, (n = 18,481)). Amblyopia was also associated with an increased risk of myocardial infarction (adjusted hazard ratio: 1.38 (1.11; 1.72)) and death (1.36 (1.15; 1.60)). On retinal imaging, amblyopic eyes had significantly increased venular caliber (0.29 units (0.21; 0.36)), increased tortuosity (0.11 units (0.03; 0.19)), but lower fractal dimension (-0.23 units (-0.30; -0.16)) and thinner ganglion cell-inner plexiform layer (mGC-IPL, -2.85 microns (-3.47; -2.22)). Unaffected fellow eyes of individuals with amblyopia also had significantly lower retinal fractal dimension (-0.08 units (-0.15; -0.01)) and thinner mGC-IPL (-1.14 microns (-1.74; -0.54)). Amblyopic eyes with a persisting visual deficit had smaller optic nerve disc height (-0.17 units (-0.25; -0.08)) and width (-0.13 units (-0.21; -0.04)) compared to control eyes.
Although further research is needed to understand the basis of the observed associations, healthcare professionals should be cognisant of greater cardiometabolic dysfunction in adults who had childhood amblyopia. Differences in retinal features in both the amblyopic eye and the unaffected non-amblyopic suggest generalised versus local processes.
Medical Research Council (MR/T000953/1) and the National Institute for Health and Care Research.
弱视是一种常见的神经发育疾病,也是儿童视力损害的主要原因。鉴于神经发育障碍与成年后期心脏代谢功能障碍之间的已知关联,我们调查了弱视儿童在成年后发生心脏代谢紊乱的风险是否增加。
这是一项对126399名接受眼科检查的英国生物银行队列参与者的横断面和纵向分析。其中67321名参与者接受了视网膜成像。数据分析于2021年11月1日至2022年10月15日进行。我们的主要目标是研究弱视与代谢综合征的多个组成部分以及个体心脏代谢疾病之间的关联。儿童弱视在成年时分为有或无弱视,心脏代谢疾病和死亡率通过眼科评估、自我报告、医院入院和死亡记录来定义。从视网膜照片和光学相干断层扫描中提取视神经、视网膜血管和各层的形态学特征。在多变量调整回归模型中研究弱视与心脏代谢紊乱以及视网膜标志物之间的关联。
持续患有弱视的个体(n = 2647)比没有弱视的个体(对照组,n = 18481)更有可能肥胖(调整后的优势比(95%置信区间):1.16(1.05;1.28))、患高血压(1.25(1.13;1.38))和患糖尿病(1.29(1.04;1.59))。弱视还与心肌梗死风险增加(调整后的风险比:1.38(1.11;1.72))和死亡风险增加(1.36(1.15;1.60))相关。在视网膜成像中,弱视眼的静脉管径显著增加(0.29个单位(0.21;0.36))迂曲度增加(0.11个单位(0.03;0.19)),但分形维数降低(-0.23个单位(-0.30;-0.16)),神经节细胞 - 内网状层(mGC - IPL)变薄(-2.85微米(-3.47;-2.22))。弱视个体未受影响的对侧眼的视网膜分形维数也显著降低(-0.08个单位(-0.15;-0.01)),mGC - IPL也变薄(-1.14微米(-1.74;-0.54))。与对照眼相比,存在持续视力缺陷的弱视眼的视神经盘高度(-0.17个单位(-0.25;-0.08))和宽度(-0.13个单位(-0.21;-0.04))更小。
尽管需要进一步研究以了解所观察到的关联的基础,但医疗保健专业人员应认识到患有儿童弱视的成年人存在更大的心脏代谢功能障碍。弱视眼和未受影响的非弱视眼视网膜特征的差异表明存在全身性与局部性过程。
医学研究理事会(MR/T000953/1)和国家卫生与保健研究所。